Table 1.
Clinical data of functionally dependent and non-functionally dependent patients.
| FDPa n (%) |
NFDPb n (%) |
χ2, p | |
|---|---|---|---|
| Disease | |||
| Hypertension | 35 (64.8) | 27 (61.4) | 0.12, 0.7 |
| Diabetes mellitus | 29 (53.7) | 14 (31.8) | 4.7, 0.03 |
| Dementia | 23 (42.6) | 15 (34.1) | 0.7, 0.39 |
| Hypercholesterolemia | 19 (35.2) | 15 (34.1) | 0.01, 0.9 |
| Osteoporosis | 14 (25.9) | 11 (25.0) | 0.01, 0.9 |
| Cerebro-vascular accident | 18 (33.3) | 4 (9.1) | 8.1, 0.004 |
| Drugs | |||
| Beta-blockers | 27 (50.0) | 13 (29.5) | 4.2, 0.04 |
| Proton-pump inhibitor | 24 (44.4) | 12 (27.3) | 3.1, 0.079 |
| Angiotensin converting enzyme inhibitors | 18 (33.3) | 14 (31.8) | 0.03, 0.89 |
| Benzodiazepines | 17 (31.5) | 13 (29.5) | 0.04, 0.84 |
| Diuretics | 18 (33.3) | 10 (22.7) | 1.3, 0.25 |
| Cholesterol lowering | 3 (5.6) | 14 (31.8) | 11.7, 0.001 |
| Acetylsalicylic acid | 2 (3.7) | 12 (27.3) | 11.0, 0.001 |
| Hypnotic | 18 (33.3) | 7 (15.9) | 3.8, 0.049 |
a
FDP - functionally dependent patients.
b
NFDP – non-functionally dependent patients.